Type 1 and type 2 diabetes are fundamentally different diseases that share a name and a diagnostic criterion. Sugar’s relationship to each is entirely different. And conflating them produces significant misunderstanding about what people with type 1 actually face.

What Causes Type 1 Diabetes

Type 1 diabetes is an autoimmune disease. The immune system, specifically autoreactive T cells, destroys the beta cells of the pancreatic islets of Langerhans that produce insulin. By the time type 1 is diagnosed, 80-90% of beta cells have already been destroyed.

The trigger for the autoimmune attack is not fully understood. Genetic risk (particularly HLA region variants) explains about 50% of susceptibility. Environmental factors, gut microbiome disruption, early viral infections, possibly reduced microbial exposure in early childhood, are thought to contribute. Eating sugar does not cause type 1 diabetes. The distinction matters whenever the two forms get discussed together: type 1 is an immune disease with no dietary cause.

Type 1 vs. Type 2: Key Differences

Feature Type 1 Type 2
Mechanism Autoimmune beta cell destruction Insulin resistance + beta cell exhaustion
Insulin production Near zero Initially high, declining over time
Onset Often sudden, usually in youth Gradual, usually in adults
Diet causation No Partially (obesity, high-sugar diet)
Primary treatment Insulin therapy (lifelong) Lifestyle change, medications, sometimes insulin
Body weight Any Often elevated

What Sugar Does in Type 1 Diabetes Management

People with type 1 diabetes still need insulin for every gram of carbohydrate they eat, including sugar. The management challenge is matching insulin doses to carbohydrate intake precisely enough to prevent both hyperglycemia (too much glucose) and hypoglycemia (too little).

Carbohydrate counting is the primary method. Every gram of carbohydrate, from bread, fruit, juice, candy, pasta, requires a calculated insulin dose. The insulin-to-carbohydrate ratio (ICR) varies by individual and time of day; a common example is 1 unit of rapid-acting insulin per 10-15g carbohydrate.

A piece of fruit (15g carbs) requires the same insulin calculation as a cookie (15g carbs). The source of the carbohydrate doesn’t affect this calculation directly, though high-GI foods produce faster glucose rises that are harder to match with subcutaneous insulin delivery, and low-GI foods are more predictable.

Hypoglycemia: When Sugar Is Medicine

When blood glucose falls below 70 mg/dL (hypoglycemia), the treatment is fast sugar — 15g of rapid glucose: regular soda, glucose tablets, juice, or candy. This “15-15 rule” (15g glucose, wait 15 minutes, recheck) uses sugar as emergency medicine.

This is why people with type 1 often carry glucose tablets, hard candy, or juice boxes, not as treats but as emergency supplies.

Hypoglycemia unawareness, where the body stops producing the warning symptoms of low blood glucose, is a dangerous complication affecting 20-40% of people with longstanding type 1. It’s associated with tight glucose control. The glucose management target that also reduces long-term complications.

The HbA1c Target

HbA1c measures average blood glucose over the past 2-3 months by quantifying glycated hemoglobin. For most adults with type 1, the American Diabetes Association recommends an HbA1c below 7% (corresponding to average glucose of about 154 mg/dL).

The DCCT (Diabetes Control and Complications Trial, 1993) established that intensive blood glucose control (HbA1c ≈7%) reduced microvascular complications (retinopathy, nephropathy, neuropathy) by 50-76% compared to conventional management. The cost was a 3-fold higher risk of severe hypoglycemia.

Continuous Glucose Monitoring and Modern Management

Modern type 1 management increasingly relies on continuous glucose monitors (CGMs) — small sensors worn on the skin that measure interstitial glucose every 5 minutes and transmit to a smartphone. Combined with insulin pumps (which deliver continuous basal insulin with meal-time boluses), CGM enables much tighter glucose control with fewer hypoglycemic events than traditional injection therapy.

This technology changes how people with type 1 relate to food: the CGM shows in real time how different foods affect glucose. Many report that this visibility changes food choices more effectively than dietary counseling alone.

See Also

Where to Read More

  • DCCT Research Group. “The effect of intensive treatment of diabetes on the development and progression of long-term complications.” NEJM 1993
  • American Diabetes Association Standards of Medical Care in Diabetes: care.diabetesjournals.org (updated annually)
  • Beyond Type 1: beyondtype1.org, patient-focused resource written by people with type 1